31.90
price up icon0.22%   0.07
after-market 시간 외 거래: 32.00 0.10 +0.31%
loading

Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스

pulisher
09:45 AM

Crinetics Pharmaceuticals (CRNX) Gets Initiated With a Hold Rating at Goldman Sachs - Insider Monkey

09:45 AM
pulisher
Jul 15, 2025

What makes Crinetics Pharmaceuticals Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Crinetics Pharmaceuticals Inc. stock attracts strong analyst attentionFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Crinetics Pharmaceuticals Inc. stock performs during market volatilityChart Based Entries - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

JMP reiterates Market Outperform rating on Crinetics stock as paltusotine shows strong data - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Teacher Retirement System of Texas Sells 1,561 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

Crinetics Reports Durable Symptom, Hormone Control With Oral Drug In Acromegaly - Benzinga

Jul 14, 2025
pulisher
Jul 14, 2025

Crinetics reveals new data from acromegaly therapy programme - Yahoo

Jul 14, 2025
pulisher
Jul 14, 2025

New data for oral acromegaly drug ahead of approval decision - The Pharma Letter

Jul 14, 2025
pulisher
Jul 14, 2025

Acromegaly's Next Frontier: Crinetics' PALSONIFY Aims to Overhaul Treatment Standards - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Crinetics Pharmaceuticals New Data Show Durable Control of Palsonify in Acromegaly - MarketScreener

Jul 14, 2025
pulisher
Jul 13, 2025

Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025 - The Manila Times

Jul 13, 2025
pulisher
Jul 13, 2025

Crinetics Pharmaceuticals Presents New Long-Term Data on PALSONIFY for Acromegaly at ENDO 2025 - Quiver Quantitative

Jul 13, 2025
pulisher
Jul 13, 2025

Breakthrough: Crinetics' Once-Daily Oral PALSONIFY Matches Injectable Treatments in 96-Week Acromegaly Study - Stock Titan

Jul 13, 2025
pulisher
Jul 13, 2025

Crinetics to Present New Long-Term Data Demonstrating Durable Co - GuruFocus

Jul 13, 2025
pulisher
Jul 12, 2025

Amalgamated Bank Boosts Stock Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

The Goldman Sachs Group Initiates Coverage on Crinetics Pharmaceuticals (NASDAQ:CRNX) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Crinetics Earnings: Q2 2025 Results and Conference Call Scheduled for August 7 After Market Close - Stock Titan

Jul 11, 2025
pulisher
Jul 11, 2025

Goldman Sachs initiates coverage on Crinetics stock with Neutral rating By Investing.com - Investing.com Canada

Jul 11, 2025
pulisher
Jul 10, 2025

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants - GuruFocus

Jul 10, 2025
pulisher
Jul 10, 2025

Crinetics Expands Team with 46 New Hires, Grants $3.2M+ in Equity Compensation - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Goldman Sachs Initiates Crinetics Pharmaceuticals at Neutral With $36 Price Target - MarketScreener

Jul 10, 2025
pulisher
Jul 08, 2025

Should You Hold Crinetics Pharmaceuticals (CRNX)? - Insider Monkey

Jul 08, 2025
pulisher
Jul 08, 2025

KBC Group NV Grows Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Jul 08, 2025
pulisher
Jul 08, 2025

Hyperparathyroidism Pipeline 2025: Groundbreaking Clinical - openPR.com

Jul 08, 2025
pulisher
Jul 06, 2025

Crinetics Pharmaceuticals’ SWOT analysis: stock poised for growth in endocrine treatments - Investing.com Australia

Jul 06, 2025
pulisher
Jul 06, 2025

Crinetics Pharmaceuticals’ SWOT analysis: stock poised for growth in endocrine treatments By Investing.com - Investing.com South Africa

Jul 06, 2025
pulisher
Jul 03, 2025

Contrasting Crinetics Pharmaceuticals (NASDAQ:CRNX) & Vaxart (NASDAQ:VXRT) - Defense World

Jul 03, 2025
pulisher
Jul 02, 2025

Crinetics stock rating reiterated at Market Outperform by JMP ahead of key data - Investing.com Canada

Jul 02, 2025
pulisher
Jun 30, 2025

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline - TradingView

Jun 30, 2025
pulisher
Jun 30, 2025

New Oral Treatment Breakthrough: Crinetics Reveals Long-Term Success Data for Acromegaly Drug at ENDO 2025 - Stock Titan

Jun 30, 2025
pulisher
Jun 28, 2025

Crinetics Pharmaceuticals’ (CRNX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Jun 28, 2025
pulisher
Jun 27, 2025

Crinetics Pharmaceuticals (CRNX) Stock Update: Analyst Maintains - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Crinetics Pharmaceuticals (CRNX) Stock Update: Analyst Maintains 'Buy' Rating | CRNX Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 22, 2025

GAMMA Investing LLC Has $227,000 Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Jun 22, 2025
pulisher
Jun 18, 2025

Trading (CRNX) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 16, 2025

Crinetics to Unveil Critical Pipeline Updates: New Data on NETs, Graves Disease, and Kidney Disease Programs - Stock Titan

Jun 16, 2025
pulisher
Jun 16, 2025

Crinetics Pharmaceuticals: Highly Priced Biotech Awaits PDUFA On Acromegaly Drug - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025 - The Manila Times

Jun 16, 2025
pulisher
Jun 14, 2025

Rhumbline Advisers Increases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Crinetics Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

Research Analysts Offer Predictions for CRNX FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CRNX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Jun 10, 2025
pulisher
Jun 05, 2025

(CRNX) Trading Report - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Sells 14,300 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Jane Street Group LLC Sells 122,188 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Thinking Of Buying Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) Stock? Here Is What You Should Know - Stocksregister

May 31, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Crinetics stock Buy rating, $81 target By Investing.com - Investing.com Canada

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Crinetics stock Buy rating, $81 target - Investing.com India

May 30, 2025
pulisher
May 26, 2025

(CRNX) Investment Report - news.stocktradersdaily.com

May 26, 2025
pulisher
May 26, 2025

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Position Lessened by D. E. Shaw & Co. Inc. - Defense World

May 26, 2025
pulisher
May 23, 2025

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025 | CRNX Stock News - GuruFocus

May 23, 2025
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
자본화:     |  볼륨(24시간):